Axitinib (Apicidin), a novel cyclic tetrapeptide, inhibits p21WAF1/CIPI by activating cyclin‐dependent kinases, which contributes to its HDAC inhibition and subsequent suppression of CRC cell proliferation [219]. The gene discussed is HDAC9; the disease is colorectal carcinoma.